← Back to Search

Montelukast for Asthma

Phase 2 & 3
Waitlist Available
Led By Jeffrey L. Blumer, M.D., Ph.D.
Research Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

The purpose of this study is to determine if montelukast, in addition to standard treatment is helpful in treating patients ages 2-5 who are in the hospital because of status asthmaticus.

Eligible Conditions
  • Asthma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of Montelukast as adjunctive therapy
Secondary outcome measures
Estimate the first dose pharmacokinetic parameters of Montelukast

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: MontelukastActive Control1 Intervention
Dissolved granules in sterile water
Group II: 1Placebo Group1 Intervention
Sterile Water

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Lead Sponsor
1,958 Previous Clinical Trials
2,673,463 Total Patients Enrolled
11 Trials studying Asthma
7,211 Patients Enrolled for Asthma
Pediatric Pharmacology Research Units NetworkNETWORK
6 Previous Clinical Trials
712 Total Patients Enrolled
1 Trials studying Asthma
52 Patients Enrolled for Asthma
Jeffrey L. Blumer, M.D., Ph.D.Principal InvestigatorPPRU

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Montelukast With Status Asthmaticus, Ages 2-5
2006. "Montelukast With Status Asthmaticus, Ages 2-5". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00491790.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top